Incyte (INCY) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 53.46% |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 43.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.81% |
| Dec 31, 2025 | 69.31% |
| Sep 30, 2025 | 57.58% |
| Jun 30, 2025 | 100.62% |
| Mar 31, 2025 | 90.93% |
| Dec 31, 2024 | 6,016.68% |
| Sep 30, 2024 | 239.22% |
| Jun 30, 2024 | -856.15% |
| Mar 31, 2024 | 202.41% |
| Dec 31, 2023 | -102.47% |
| Sep 30, 2023 | -63.18% |
| Jun 30, 2023 | 75.68% |
| Mar 31, 2023 | -165.37% |
| Dec 31, 2022 | 346.36% |
| Sep 30, 2022 | 24.96% |
| Jun 30, 2022 | 39.30% |
| Mar 31, 2022 | 25.07% |
| Dec 31, 2021 | 254.18% |
| Sep 30, 2021 | 20.41% |
| Jun 30, 2021 | -54.88% |
| Mar 31, 2021 | 120.16% |
| Dec 31, 2020 | -87.42% |
| Sep 30, 2020 | -40.97% |
| Jun 30, 2020 | 141.85% |
| Mar 31, 2020 | -682.27% |
| Dec 31, 2019 | 152.70% |
| Sep 30, 2019 | 55.46% |
| Jun 30, 2019 | 243.16% |
| Mar 31, 2019 | 2,761.18% |
| Dec 31, 2018 | 122.67% |
| Sep 30, 2018 | -72.84% |
| Jun 30, 2018 | -62.18% |
| Mar 31, 2018 | 98.25% |
| Dec 31, 2017 | -492.59% |
| Sep 30, 2017 | 631.55% |
| Jun 30, 2017 | 152.96% |
| Mar 31, 2017 | -313.32% |
| Dec 31, 2016 | -23.03% |
| Sep 30, 2016 | 1,410.54% |
| Jun 30, 2016 | -1,051.60% |
| Mar 31, 2016 | 546.84% |
| Dec 31, 2015 | 7.59% |
| Sep 30, 2015 | 125.23% |
| Jun 30, 2015 | 158.90% |
| Mar 31, 2015 | 12.54% |
| Dec 31, 2014 | -64.73% |
| Sep 30, 2014 | -274.28% |
| Jun 30, 2014 | -298.33% |
| Mar 31, 2014 | -183.44% |
| Dec 31, 2013 | 1,426.41% |
| Sep 30, 2013 | 175.32% |
| Jun 30, 2013 | -129.61% |
| Mar 31, 2013 | 201.08% |
| Dec 31, 2012 | 61.63% |
| Sep 30, 2012 | 60.47% |
| Jun 30, 2012 | 236.97% |
| Mar 31, 2012 | -3.09% |
| Dec 31, 2011 | -234.55% |
| Sep 30, 2011 | -84.88% |
| Jun 30, 2011 | -300.91% |
| Mar 31, 2011 | 11.11% |